Invesco Ltd. Grows Holdings in Bausch Health Companies Inc. (NYSE:BHC)

Invesco Ltd. raised its position in Bausch Health Companies Inc. (NYSE:BHC) by 14.5% during the second quarter, Holdings Channel.com reports. The firm owned 512,790 shares of the company’s stock after buying an additional 64,798 shares during the period. Invesco Ltd.’s holdings in Bausch Health Companies were worth $15,034,000 at the end of the most recent quarter.

A number of other large investors have also recently added to or reduced their stakes in BHC. Heritage Wealth Advisors purchased a new position in Bausch Health Companies in the 2nd quarter valued at about $42,000. Tarbox Family Office Inc. purchased a new position in shares of Bausch Health Companies during the 2nd quarter worth about $59,000. Quadrant Capital Group LLC lifted its holdings in shares of Bausch Health Companies by 21.6% during the 2nd quarter. Quadrant Capital Group LLC now owns 2,761 shares of the company’s stock worth $81,000 after acquiring an additional 490 shares during the period. Rockefeller Capital Management L.P. lifted its holdings in shares of Bausch Health Companies by 1,084.7% during the 2nd quarter. Rockefeller Capital Management L.P. now owns 3,495 shares of the company’s stock worth $102,000 after acquiring an additional 3,200 shares during the period. Finally, Advisory Services Network LLC purchased a new position in shares of Bausch Health Companies during the 2nd quarter worth about $107,000. Institutional investors own 75.43% of the company’s stock.

Shares of NYSE:BHC opened at $26.11 on Thursday. Bausch Health Companies Inc. has a 52-week low of $18.49 and a 52-week high of $34.80. The company has a 50 day moving average of $27.70 and a two-hundred day moving average of $28.71. The company has a market capitalization of $9.37 billion, a price-to-earnings ratio of -7.96, a price-to-earnings-growth ratio of 1.45 and a beta of 1.56.

Bausch Health Companies (NYSE:BHC) last issued its quarterly earnings data on Tuesday, November 2nd. The company reported $1.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of $1.07 by $0.07. Bausch Health Companies had a negative net margin of 13.85% and a negative return on equity of 2,440.75%. The company had revenue of $2.11 billion during the quarter, compared to the consensus estimate of $2.15 billion. On average, equities research analysts anticipate that Bausch Health Companies Inc. will post 4.23 EPS for the current year.

BHC has been the topic of several recent analyst reports. Royal Bank of Canada cut their price objective on shares of Bausch Health Companies from $41.00 to $40.00 and set an “outperform” rating on the stock in a report on Wednesday, November 3rd. Barclays cut their price objective on shares of Bausch Health Companies from $35.00 to $31.00 and set an “overweight” rating on the stock in a report on Wednesday, August 4th. Jefferies Financial Group reissued a “buy” rating on shares of Bausch Health Companies in a research report on Friday, October 1st. Finally, BMO Capital Markets reissued a “hold” rating on shares of Bausch Health Companies in a research report on Monday, November 8th. One analyst has rated the stock with a sell rating, three have issued a hold rating and five have given a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Hold” and an average target price of $36.22.

About Bausch Health Companies

Bausch Health Cos., Inc engages in the development, manufacture and market of a range of branded, generic and branded generic pharmaceuticals, medical devices and over-the-counter products. It operates through the following segments: The Bausch + Lomb/International, Salix, Ortho Dermatologics and Diversified Products.

Read More: Analyst Ratings Trading

Want to see what other hedge funds are holding BHC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Bausch Health Companies Inc. (NYSE:BHC).

Institutional Ownership by Quarter for Bausch Health Companies (NYSE:BHC)

Receive News & Ratings for Bausch Health Companies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bausch Health Companies and related companies with MarketBeat.com's FREE daily email newsletter.